Previous 10 | Next 10 |
2023-12-13 13:37:28 ET More on AmWell, Teladoc, etc. Teladoc: High Stock Compensation Is An Issue Teladoc: No Floor Yet Teladoc's Valuation Proposition: 7x EBITDA In 2024, Not So Bad Global telemedicine market to hit $450B in 2032: report American Wel...
2023-12-12 19:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-08 09:15:00 ET A couple of years ago many companies took an untraditional route to the public markets. An investment vehicle called a special purpose acquisition company ( SPAC ) saw a resurgence in activity. SPACs are more colloquially referred to as "blank check companies," an...
2023-12-05 12:00:00 ET Summary In November, we welcomed 24 new analysts who published their first article on Seeking Alpha. This series highlights and welcomes these newcomers to our ranks of analysts who share their unique insights and perspectives as well as some of their top in...
Weight Loss by Hims & Hers is designed to help people achieve and maintain their weight-loss goals with personalized and affordable clinical programs that combine medication management, digital tracking tools and customized educational content Obesity medicine pioneer Craig Primack, M...
2023-11-30 11:00:00 ET Summary Hims & Hers Health exhibits similarities to previous "100 Bagger" stocks, which I believe the market has not noticed at all. I wanted to bring this to the forefront. The company has the potential to be a transformative force in healthcare, with a...
2023-11-29 08:30:00 ET The stock market averages about 10 percent annual returns over the long term. If you wanted a stock to increase by 10X over 10 years, that would require an average annual return of 26%. Clearly, beating the stock market isn't easy. Stocks that do it generally must hav...
2023-11-26 11:53:37 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The telehealth sector is undergoing a significant transformation, reshaping the traditional contours of medical service delivery. This innovation-driven domain is drawing attention from investo...
2023-11-16 06:15:00 ET Hims & Hers Health (NYSE: HIMS) is one of the fastest-growing stocks in the healthcare industry. While it has started out by focusing on niches and helping people with sensitive issues such as erectile dysfunction, it is branching out into larger areas, wh...
2023-11-08 15:51:57 ET Summary Hims & Hers posted another beat on revenue-and-raise quarter — execution has been on-point. Price cuts had no negative impact on Gross Margins. Instead, it expanded to its highest ever. The company's Payback Period looks great, but CAC...
News, Short Squeeze, Breakout and More Instantly...
Hims & Hers Health Inc. Class A Company Name:
HIMS Stock Symbol:
NYSE Market:
Hims & Hers Health Inc. Class A Website:
Bringing experience from Novo Nordisk and Teva Pharmaceutical Industries, Schultz joins the Hims & Hers Board of Directors to help the company increase access to health and wellness solutions Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading hea...
2024-07-20 09:00:00 ET With shares up a blistering 150% year to date, Hims & Hers Health (NYSE: HIMS) boasts everything an investor could dream of these days: rapid expansion, a vast addressable market, and a reasonable valuation. Let's explore why it is my top growth ...
Hims & Hers Health, Inc. ("Hims & Hers") (NYSE: HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5...